133 related articles for article (PubMed ID: 11169961)
1. Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence.
Johnsen AK; France J; Nagy N; Askew D; Abdul-Karim FW; Gerson SL; Sy MS; Harding CV
Int J Cancer; 2001 Feb; 91(3):366-72. PubMed ID: 11169961
[TBL] [Abstract][Full Text] [Related]
2. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
Singal DP; Ye M; Ni J; Snider DP
Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
[TBL] [Abstract][Full Text] [Related]
3. The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2.
Hayashi T; Kobayashi Y; Kohsaka S; Sano K
Oncogene; 2006 Jul; 25(29):4016-26. PubMed ID: 16474838
[TBL] [Abstract][Full Text] [Related]
4. Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression.
Chatterjee-Kishore M; Kishore R; Hicklin DJ; Marincola FM; Ferrone S
J Biol Chem; 1998 Jun; 273(26):16177-83. PubMed ID: 9632673
[TBL] [Abstract][Full Text] [Related]
5. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter.
Wright KL; White LC; Kelly A; Beck S; Trowsdale J; Ting JP
J Exp Med; 1995 Apr; 181(4):1459-71. PubMed ID: 7699330
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter.
Yan G; Fu Y; Faustman DL
J Immunol; 1997 Sep; 159(6):3068-80. PubMed ID: 9300732
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.
Johnsen AK; Templeton DJ; Sy M; Harding CV
J Immunol; 1999 Oct; 163(8):4224-31. PubMed ID: 10510359
[TBL] [Abstract][Full Text] [Related]
8. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
[TBL] [Abstract][Full Text] [Related]
9. Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice.
White LC; Wright KL; Felix NJ; Ruffner H; Reis LF; Pine R; Ting JP
Immunity; 1996 Oct; 5(4):365-76. PubMed ID: 8885869
[TBL] [Abstract][Full Text] [Related]
10. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function.
Ritz U; Momburg F; Pircher HP; Strand D; Huber C; Seliger B
Int Immunol; 2001 Jan; 13(1):31-41. PubMed ID: 11133832
[TBL] [Abstract][Full Text] [Related]
11. High frequency of a non-functional TAP1/LMP2 promoter polymorphism in human tumors.
Seliger B; Bock M; Ritz U; Huber C
Int J Oncol; 2002 Feb; 20(2):349-53. PubMed ID: 11788900
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of mouse anti-human LMP2, LMP7, TAP1 and TAP2 monoclonal antibodies.
Kishore R; Hicklin DJ; Dellaratta DV; Golde U; Kageshita T; Seliger B; Ferrone S
Tissue Antigens; 1998 Feb; 51(2):129-40. PubMed ID: 9510369
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines.
Johnsen A; France J; Sy MS; Harding CV
Cancer Res; 1998 Aug; 58(16):3660-7. PubMed ID: 9721876
[TBL] [Abstract][Full Text] [Related]
14. Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors.
Qin Z; Harders C; Cao X; Huber C; Blankenstein T; Seliger B
Cancer Res; 2002 May; 62(10):2856-60. PubMed ID: 12019164
[TBL] [Abstract][Full Text] [Related]
15. IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells.
Jamaluddin M; Wang S; Garofalo RP; Elliott T; Casola A; Baron S; Brasier AR
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L248-57. PubMed ID: 11159003
[TBL] [Abstract][Full Text] [Related]
16. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
[TBL] [Abstract][Full Text] [Related]
17. Impaired transporter associated with antigen processing (TAP) function attributable to a single amino acid alteration in the peptide TAP subunit TAP1.
Ritz U; Drexler I; Sutter D; Abele R; Huber C; Seliger B
J Immunol; 2003 Jan; 170(2):941-6. PubMed ID: 12517960
[TBL] [Abstract][Full Text] [Related]
18. Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression.
Li XL; Liu YY; Knight D; Odaka Y; Mathis JM; Shi R; Glass J; Zhang QJ
PLoS One; 2009 Jul; 4(7):e6385. PubMed ID: 19629186
[TBL] [Abstract][Full Text] [Related]
19. The expression of MHC class I, TAP1/2, and LMP2/7 gene in human gastric cancer cell lines.
Kang JK; Yoon SJ; Kim NK; Heo DS
Int J Oncol; 2000 Jun; 16(6):1159-63. PubMed ID: 10811990
[TBL] [Abstract][Full Text] [Related]
20. MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice.
Ljunggren HG; Van Kaer L; Sabatine MS; Auchincloss H; Tonegawa S; Ploegh HL
Int Immunol; 1995 Jun; 7(6):975-84. PubMed ID: 7577806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
